1. Home
  2. AEIS vs GH Comparison

AEIS vs GH Comparison

Compare AEIS & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEIS
  • GH
  • Stock Information
  • Founded
  • AEIS 1981
  • GH 2011
  • Country
  • AEIS United States
  • GH United States
  • Employees
  • AEIS N/A
  • GH N/A
  • Industry
  • AEIS Industrial Machinery/Components
  • GH Medical Specialities
  • Sector
  • AEIS Technology
  • GH Health Care
  • Exchange
  • AEIS Nasdaq
  • GH Nasdaq
  • Market Cap
  • AEIS 4.1B
  • GH 3.0B
  • IPO Year
  • AEIS 1995
  • GH 2018
  • Fundamental
  • Price
  • AEIS $98.00
  • GH $26.25
  • Analyst Decision
  • AEIS Buy
  • GH Strong Buy
  • Analyst Count
  • AEIS 10
  • GH 17
  • Target Price
  • AEIS $113.25
  • GH $39.31
  • AVG Volume (30 Days)
  • AEIS 214.1K
  • GH 2.3M
  • Earning Date
  • AEIS 10-29-2024
  • GH 11-04-2024
  • Dividend Yield
  • AEIS 0.41%
  • GH N/A
  • EPS Growth
  • AEIS N/A
  • GH N/A
  • EPS
  • AEIS 2.39
  • GH N/A
  • Revenue
  • AEIS $1,507,684,000.00
  • GH $643,810,000.00
  • Revenue This Year
  • AEIS N/A
  • GH $27.01
  • Revenue Next Year
  • AEIS $16.27
  • GH $18.30
  • P/E Ratio
  • AEIS $40.06
  • GH N/A
  • Revenue Growth
  • AEIS N/A
  • GH 26.20
  • 52 Week Low
  • AEIS $81.86
  • GH $15.81
  • 52 Week High
  • AEIS $119.75
  • GH $37.04
  • Technical
  • Relative Strength Index (RSI)
  • AEIS 42.39
  • GH 47.12
  • Support Level
  • AEIS $92.13
  • GH $24.55
  • Resistance Level
  • AEIS $109.28
  • GH $25.87
  • Average True Range (ATR)
  • AEIS 2.84
  • GH 1.13
  • MACD
  • AEIS -0.64
  • GH 0.18
  • Stochastic Oscillator
  • AEIS 27.19
  • GH 69.88

About AEIS Advanced Energy Industries Inc.

Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in the United States, with the rest primarily from Asia and Europe.

About GH Guardant Health Inc.

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: